These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1641769)

  • 1. Beneficial effect of syngeneic pancreatic islet transplantation on liver atrophy and hepatocellular function after portacaval shunt.
    Nakafusa Y; Goss JA; Roland CR; Lacy PE; Flye MW
    Surgery; 1992 Aug; 112(2):309-17; discussion 317-8. PubMed ID: 1641769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic insufficiency after portacaval shunting is prevented by prior intraportal pancreatic islet autotransplantation.
    Callery MP; Ricordi C; Scharp DW; Kamei T; Swanson CJ; Lacy PE; Flye MW
    Surgery; 1989 Aug; 106(2):257-65; discussion 265-6. PubMed ID: 2503900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterotopic liver transplantation in rats: effect of intrahepatic islet isografts and split portal blood flow on liver integrity after auxiliary liver isotransplantation.
    Yu W; Wan X; Wright JR; Coddington D; Bitter-Suermann H
    Surgery; 1994 Jan; 115(1):108-17. PubMed ID: 8284751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of liver atrophy by intraportal syngeneic pancreatic islet transplantation before portacaval shunt.
    Kamei T; Callery MP; Ricordi C; Lacy PE; Flye MW
    Transplantation; 1989 Nov; 48(5):870-2. PubMed ID: 2510376
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of arterialisation of the portal stump on liver function and hepatic haemodynamics in cirrhotic rats with a portacaval shunt.
    Jenkins SA; Baxter JN; Devitt P; Shimirty SK; Shields R
    Digestion; 1986; 33(3):161-7. PubMed ID: 3949094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the numbers of islets on the models of rat syngeneic-islet and allogeneic-islet transplantations.
    Hara Y; Fujino M; Nakada K; Kimura K; Adachi K; Li XK
    Transplant Proc; 2006 Oct; 38(8):2726-8. PubMed ID: 17098051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in hepatic blood flow after various types of portal shunt in the rat].
    Castaing D; Crestanello F; Morin J; Bismuth H
    Gastroenterol Clin Biol; 1983 Apr; 7(4):335-9. PubMed ID: 6873546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of intraportal syngeneic pancreatic islet transplantation after portacaval shunt in rats.
    Nakafusa Y; Goss JA; Roland CR; Lacy PE; Flye MW
    Transplant Proc; 1992 Dec; 24(6):2916. PubMed ID: 1465998
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic functional deterioration after portacaval shunt in the rat. Effects on sulfobromophthalein transport-maximum, indocyanine green clearance and galactose elimination capacity.
    Lauterburg BH; Sautter V; Preisig R; Bircher J
    Gastroenterology; 1976 Aug; 71(2):221-7. PubMed ID: 939381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver atrophy and encephalopathy after portacaval shunt in the rat.
    Castaing D; Beaubernard C; Ariogul O; Gigou M; Franco D; Bismuth H
    Eur Surg Res; 1982; 14(3):192-202. PubMed ID: 7117325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative studies of liver atrophy after portacaval shunt in the rat.
    Zaitoun AA; Apelqvist G; Al-Mardini H; Gray T; Bengtsson F; Record CO
    J Surg Res; 2006 Apr; 131(2):225-32. PubMed ID: 16427088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.
    Gandhi CR; Murase N; Subbotin VM; Uemura T; Nalesnik M; Demetris AJ; Fung JJ; Starzl TE
    J Hepatol; 2002 Sep; 37(3):340-8. PubMed ID: 12175629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension.
    Zhang ZT; Jiang P; Wang Y; Li JS; Xue JG; Zhou YZ; Yuan Z
    Chin Med J (Engl); 2006 Oct; 119(20):1727-33. PubMed ID: 17097021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver arterialization prevents thrombocytopenia after portacaval shunt in rats.
    Aseni P; Beati CA; Vertemati M; Meroni A; Belli L
    Eur Surg Res; 1987; 19(3):159-63. PubMed ID: 3609078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt.
    Fisher B; Gebhardt MC; Saffer EA; Fisher ER
    Surg Gynecol Obstet; 1979 Aug; 149(2):168-72. PubMed ID: 462347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of postshunt liver failure.
    Reichle FA; Rao NS; Reichle RM; Chang KH
    Surgery; 1977 Nov; 82(5):738-49. PubMed ID: 918862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of transplanted pancreatic islets in the rat.
    Franklin WA; Schulak JA; Reckard CR
    Am J Pathol; 1979 Jan; 94(1):85-95. PubMed ID: 104625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic islets transplanted intraportally maintain hepatic integrity following portacaval shunt in rats.
    Kamei T; Falqui L; Lacy PE; Callery MP; Flye MW
    Transplant Proc; 1990 Apr; 22(2):810-3. PubMed ID: 2158176
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver bacterial clearance following hepatic artery ligation and portacaval shunt.
    Katz S; Jimenez MA; Lehmkuhler WE; Grosfeld JL
    J Surg Res; 1991 Sep; 51(3):267-70. PubMed ID: 1881140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device.
    Pileggi A; Molano RD; Ricordi C; Zahr E; Collins J; Valdes R; Inverardi L
    Transplantation; 2006 May; 81(9):1318-24. PubMed ID: 16699461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.